Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (1-10 of 272) with videos related to

Pageof 28
Sort By:
Nature Biotechnology|January 11, 2007
Lentiviral vectors ready for prime-timeDonald B Kohn
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2002
Adenosine deaminase gene therapy protocol revisitedDonald B Kohn
Blood|June 6, 2015
Gene therapy outpaces haplo for SCID-X1Donald B Kohn
Blood|September 16, 2017
Gene therapy: WAS (not) just for kidsDonald B Kohn
Current Opinion in Biotechnology|January 2, 2019
Gene therapy for blood diseasesDonald B Kohn
Hematology. American Society of Hematology. Education Program|February 20, 2015
Eliminating SCID row: new approaches to SCIDDonald B Kohn
Clinical Immunology (Orlando, Fla.)|January 15, 2010
Update on gene therapy for immunodeficienciesDonald B Kohn
Immunological Reviews|November 30, 2023
Gene therapy for adenosine deaminase severe combined immune deficiency-An unexpected journey of four decadesDonald B Kohn
Hematology/Oncology Clinics of North America|September 13, 2017
Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene TherapyDonald B Kohn
Cytotherapy|February 13, 2019
Chemistry, manufacturing and controls for gene modified hematopoietic stem cellsSandeep Soni, Donald B Kohn
Pageof 28

Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Nature Biotechnology|January 11, 2007
Lentiviral vectors ready for prime-timeDonald B Kohn
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 7, 2002
Adenosine deaminase gene therapy protocol revisitedDonald B Kohn
Blood|June 6, 2015
Gene therapy outpaces haplo for SCID-X1Donald B Kohn
Blood|September 16, 2017
Gene therapy: WAS (not) just for kidsDonald B Kohn
Current Opinion in Biotechnology|January 2, 2019
Gene therapy for blood diseasesDonald B Kohn
Hematology. American Society of Hematology. Education Program|February 20, 2015
Eliminating SCID row: new approaches to SCIDDonald B Kohn
Clinical Immunology (Orlando, Fla.)|January 15, 2010
Update on gene therapy for immunodeficienciesDonald B Kohn
Immunological Reviews|November 30, 2023
Gene therapy for adenosine deaminase severe combined immune deficiency-An unexpected journey of four decadesDonald B Kohn
Hematology/Oncology Clinics of North America|September 13, 2017
Historical Perspective on the Current Renaissance for Hematopoietic Stem Cell Gene TherapyDonald B Kohn
Cytotherapy|February 13, 2019
Chemistry, manufacturing and controls for gene modified hematopoietic stem cellsSandeep Soni, Donald B Kohn
Pageof 28